Three new studies from WCLC 2026 show strong results in ROS1-positive NSCLC, EGFR-mutant NSCLC and relapsed small cell lung ...

Local transplant availability reduced patient travel burden and preserved continuity for long-term oncology relationships, reinforcing the program’s mission around access and community-based care.

Irene Flores' advocacy for bedside nurses helped build a local stem cell transplant program, making her an Extraordinary Healer Award nominee.

FDA approves Inluriyo plus Verzenio for adults with ESR1-mutated, ER-positive, HER2-negative advanced or metastatic breast ...

In this Q&A, Dr. Dina Khalaf, a clinical associate professor in the University of Florida Division of Hematology and Oncology ...

After having cancer, travelling can become more than a getaway. It can be part of your emotional recovery. Rest, joy, and ...

Venesection, the term used in the United Kingdom for therapeutic phlebotomy, has long been a standard treatment for PV. The procedure removes blood to help keep red blood cell levels under control, ...

Patients in CONVERGE have stage 3 lung cancer and receive chemotherapy and radiation at the same time, followed by the immunotherapy Imfinzi (durvalumab) given by IV. Even with that treatment, fully ...

September is Blood Cancer Awareness Month, and the pipeline for leukemia, lymphoma and myeloma is as active as it has been in years. One CAR T-cell therapy for multiple myeloma is awaiting an FDA ...

A peritoneal mesothelioma diagnosis at 21, five months postpartum, underscores the psychosocial burden of rare malignancy in ...